Fortunis capital investment in biotec Stemson makes the headlines on tv

Fortunis Capital and Allergan Aesthetics’ £6million investment to support Stemson Therapeutic’s ground-breaking solution to cure hair loss made the headlines on Local TV, a major UK network that reaches 4.5million viewers a month.

Interviewer Emily Bonner asked Sir Andrew Ross, our director of investments, about Stemson’s mission to restore human hair growth using the patient’s own cells to generate new hair follicles.

Fortunis Capital and Allergan Aesthetics’ £6million investment to support Stemson Therapeutic’s ground-breaking solution to cure hair loss made the headlines on Local TV, a major UK network that reaches 4.5million viewers a month. Interviewer Emily Bonner asked Sir Andrew Ross, our director of investments, about Stemson’s mission to restore human hair growth using the patient’s own cells to generate new hair follicles.